August 2, 2015
Recommended Topic Related To:

Cenestin

"Oct. 24, 2012 -- Women who take hormones within five years of menopause may have a slightly lower risk of Alzheimer's disease compared to women who don't ever take them, a new study shows.

The study, which is published in the journal"...

Cenestin




Indications
Dosage
How Supplied

INDICATIONS

Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause

Treatment Of Moderate To Severe Symptoms Of Vulvar And Vaginal Atrophy due to Menopause

Limitation of Use

When prescribing solely for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause, topical vaginal products should be considered.

DOSAGE AND ADMINISTRATION

Generally, when estrogen is prescribed for a postmenopausal woman with a uterus, a progestin should also be considered to reduce the risk of endometrial cancer.

A woman without a uterus does not need progestin. In some cases, however, hysterectomized women with a history of endometriosis may need a progestin [see WARNINGS AND PRECAUTIONS].

Use of estrogen-alone, or in combination with a progestin, should be with the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman. Postmenopausal women should be reevaluated periodically as clinically appropriate to determine if treatment is still necessary.

Treatment Of Moderate To Severe Vasomotor Symptoms Due To Menopause

Cenestin therapy consists of a single tablet taken orally once daily.

  • Cenestin 0.45 mg
  • Cenestin 0.625 mg
  • Cenestin 0.9 mg
  • Cenestin 1.25 mg

Patients should be started at Cenestin 0.45 mg daily. Subsequent dosage adjustment may be made based upon the individual patient response. This dose should be periodically reassessed by the healthcare provider. The lowest effective dose of Cenestin for the treatment of moderate to severe vasomotor symptoms has not been determined.

Treatment Of Moderate To Severe Symptoms Of Vulvar And Vaginal Atrophy Due To Menopause

Cenestin therapy consists of a single tablet taken orally once daily.

  • Cenestin 0.3 mg

When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered.

HOW SUPPLIED

Dosage Forms And Strengths

Cenestin (synthetic conjugated estrogens, A) Tablets are available as:

0.3 mg round, green, film-coated tablets debossed with the letters, dp, on one side and the number 41 on the other side.

0.45 mg round, orange, film-coated tablets debossed with the letters, dp, on one side and the number 46 on the other side.

0.625 mg round, red, film-coated tablets debossed with the letters, dp, on one side and the number 42 on the other side.

0.9 mg round, white, film-coated tablets debossed with the letters, dp, on one side and the number 43 on the other side.

1.25 mg round, blue, film-coated tablets debossed with the letters, dp, on one side and the number 44 on the other side.

How Supplied

Cenestin (synthetic conjugated estrogens, A) Tablets are available as:

0.3 mg Round, green, film-coated, and are debossed with the letters, dp, on one side and the number, 41 on the other side. Available in bottles of: 100 NDC 51285-441-02
0.45 mg Round, orange, film-coated, and are debossed with the letters, dp, on one side and the number, 46 on the other side. Available in bottles of: 100 NDC 51285-446-02
0.625 mg Round, red, film-coated, and are debossed with the letters, dp, on one side and the number, 42 on the other side. Available in bottles of: 100 NDC 51285-442-02
0.9 mg Round, white, film-coated, and are debossed with the letters, dp, on one side and the number, 43 on the other side. Available in bottles of: 100 NDC 51285-443-02
1.25 mg Round, blue, film-coated, and are debossed with the letters, dp, on one side and the number, 44 on the other side. Available in bottles of: 100 NDC 51285-444-02

Storage And Handling

Store at 20 to 25°C (68-77°F); excursions are permitted to 15 to 30°C (59 to 86°F) [See USP Controlled Room Temperature]. Dispense in tight container. Dispense in child-resistant packaging. Keep out of the reach of children. Pharmacist: Include one “Information for the patient” leaflet with each package dispensed.

Manufactured By: Teva Women's Health, Inc. Subsidiary of Teva Pharmaceuticals USA, Inc. North Wales, PA 19454. Revised: 03/2015

Last reviewed on RxList: 4/6/2015
This monograph has been modified to include the generic and brand name in many instances.

Indications
Dosage
How Supplied

Cenestin - User Reviews

Cenestin User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Cenestin sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.